C. STOCKHOLDERS EQUITY (Tables)

9 Months Ended

Jun. 30, 2013

C. Stockholders Equity Tables

Stock options, stock bonuses and compensation granted by the Company

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued as Stock Bonus Compensation		Remaining Options/Shares Under Plans
Incentive Stock Option Plans		21,100,000		13,898,275		N/A		3,245,225
Non-Qualified Stock Option
Plans		57,760,000		34,476,781		N/A		16,761,069
Stock Bonus Plans		15,940,000		N/A		8,707,753		7,224,685
Stock Compensation Plan		13,500,000		N/A		6,886,531		6,613,469

Schedule of employees and non-employees stock compensation

Stock-Based Compensation Expense

	Nine months Ended June 30,
	2013		2012
Employees	$	2,087,718	$	1,761,365
Non-employees	$	364,318	$	457,497

	Three months Ended June 30,
	2013		2012
Employees	$	564,369	$	463,314
Non-employees	$	155,963	$	213,789

Derivative Liabilities, Warrants and Other Options

Below is a chart showing the derivative liabilities and the number of warrants outstanding at June 30, 2013:

Warrant	Issue Date	Shares Issuable upon Exercise of Warrant		Exercise Price		Expiration Date	Reference
Series N	8/18/08		5,187,709		0.30	8/18/14		1
Series A	6/24/09		1,303,472		0.50	12/24/14		1
C. Schleuning (Series A)	7/8/09		167,500		0.50	1/8/15		1
Series B	9/4/09		500,000		0.68	9/4/14		1
Series C	8/20/09 - 8/26/09		4,634,886		0.55	2/20/15		1
Series E	9/21/09		714,286		1.75	8/12/14		1
Series F	10/6/11		12,000,000		0.40	10/6/14		1
Series G	10/6/11		666,667		0.40	8/12/14		1
Series H	1/26/12		12,000,000		0.50	8/1/15		1
Series Q	6/21/12		12,000,000		0.50	12/22/15		1
Series R	12/6/12		26,250,000		0.40	12/6/16		1
Series L	4/18/07		250,000		0.75	4/17/14		2
Series L (repriced)	4/18/07		700,000		0.25	4/2/15		2
Series M (modified)	4/18/07		6,000,000		0.34	7/31/14		2
Series P	2/10/12		5,900,000		0.45	3/6/17		3
Private Investors	7//18/05- 6/30/09		7,409,375		0.56 - 0.82	1/26/14 - 7/18/14		4
Warrants held by Officer and Director	6/24/09- 7/6/09		3,497,539		0.40 - 0.50	12/24/14 - 1/6/15		5
Consultants	2/15/05 - 12/28/12		1,407,500		0.28 - 2.00	5/20/14 – 12/27/17		6

Tabular disclosure of derivative liabilities at fair value

See below for details of the balances of derivative instruments at June 30, 2013 and September 30, 2012.

	June 30, 2013		September 30, 2012
Series A through E warrants	$	127,118	$	786,989
Series N warrants		259,385		830,034
Series F and G warrants		253,333		1,646,667
Series H warrants		480,000		1,800,000
Series Q warrants		600,000		1,920,000
Series R warrants		2,100,000		-
Total derivative liabilities	$	3,819,836	$	6,983,690